Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of freeze-dried human diploid cell rabies vaccine using different immunization schedules in healthy participants
CTR20242601Phase 3Active
- Sponsor
- Pukang Biotechnology
- Start
- Jul 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of rabies virus inactivated antigen, B in rabies, sponsored by Pukang Biotechnology. Started Jul 2024; status: active.
02
Drugs
rabies virus inactivated antigen, B
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20242601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242601.